SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments
.png)
Despite a resurgence in COVID-19 that impacted procedure volumes early in Q121, the SCS Market’s climb t...
Dan Volz, President of Medtronic Neurovascular, discusses what’s next for Medtronic Neurovascular in an ...
Aure Bruneau, CEO of Stimwave, discusses his vision for the Company and taking peripheral nerve stimulat...
SmartTRAK is pleased to announce the addition of the Deep Brain Stimulation (DBS) module to our business...
While US SCS revenues were almost back to pre-COVID levels in Q320, rising COVID case rates put the brak...
In an interview with SmartTRAK, Keith Boettiger, VP of Abbott Neuromodulation, discusses the Company’s n...
Despite the continuing challenges posed by the pandemic, the MedTech industry presses on with product in...
Nilesh Patel, MD, vice president of medical affairs for Boston Scientific, discusses the Company’s lates...
Charlie Covert, Medtronic’s VP/GM of Pain Therapies, discusses the Company’s neuromodulation news at NAN...
The US Spinal Cord Stimulation Market saw a ray of sunshine in Q320 as revenues recovered to almost pre-...
Login